Summary by Moomoo AI
Elisabeth Leiderman, associated with bluebird bio, Inc. [BLUE], completed a stock acquisition on November 6, 2024. The transaction involved a grant of 24,900 shares of common stock at no cost. Following the transaction, Leiderman's direct holdings in the company increased to a total of 47,156 shares. The grant is part of the company's compensation structure and reflects the ongoing commitment of its executives to the company's success.